Sale!

Immunohistochemistry CD45 LCA Test Cost

Original price was: 460 د.إ.Current price is: 410 د.إ.

-11%

The Immunohistochemistry CD45 LCA (Leukocyte Common Antigen) test is a specialized diagnostic procedure employed to detect the presence of CD45, a protein found on the surface of white blood cells (leukocytes). This test plays a crucial role in the diagnosis and classification of hematopoietic (blood cell-originating) tumors, including various types of leukemia and lymphoma. By identifying the CD45 antigen, pathologists can determine the lineage of the cells, distinguishing between lymphoid and myeloid malignancies, and thus guiding appropriate treatment strategies.

Performed on tissue samples, this immunohistochemical staining technique involves the application of antibodies specific to the CD45 antigen. These antibodies are visualized under a microscope, allowing for the precise identification of cells expressing CD45. This method not only aids in diagnosing hematological cancers but also helps in differentiating them from other non-hematopoietic neoplasms, which do not express CD45.

In the United Arab Emirates, the Immunohistochemistry CD45 LCA Test is available at DNA Labs UAE, a reputable laboratory known for its advanced diagnostic services. The cost of the test is 410 AED, making it accessible for patients requiring detailed analysis for accurate diagnosis and treatment planning. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure reliable and timely results, contributing significantly to patient care in the field of oncology and hematology.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY CD45 LCA Test

Cost: AED 410.0

At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY CD45 LCA Test for diagnosing and characterizing certain types of cells in tissue samples. This test is commonly used in pathology and can provide valuable information for prognosis and treatment decisions.

Test Components

Price: AED 410.0

Sample Condition

Please submit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. The sample should be shipped at room temperature. Additionally, provide a copy of the Histopathology report, site of biopsy, and clinical history.

Report Delivery

Sample: Daily by 6 pm

Report Block: 5 days

Tissue Biopsy: 5 days

Tissue large complex: 7 days

Method

The IMMUNOHISTOCHEMISTRY CD45 LCA Test utilizes immunohistochemistry to identify and characterize cells in tissue samples.

Test Type

This test is specifically used for diagnosing cancer.

Doctor

This test is typically ordered by an oncologist or pathologist.

Test Department

The IMMUNOHISTOCHEMISTRY CD45 LCA Test is conducted in our Test Department.

Pre Test Information

Before conducting the test, please provide a copy of the Histopathology report, site of biopsy, and clinical history.

Test Details

The IMMUNOHISTOCHEMISTRY CD45 LCA Test involves staining tissue sections with antibodies specific to CD45. CD45, also known as leukocyte common antigen (LCA), is a protein present on the surface of all white blood cells (leukocytes). By binding to CD45 protein, the antibodies allow for the identification and localization of leukocytes within the tissue sample.

This test can be performed on formalin-fixed, paraffin-embedded tissue sections or frozen tissue sections. It is commonly used to differentiate between malignant and non-malignant cells in various types of cancers. Additionally, it helps determine the presence and distribution of leukocytes within the tumor microenvironment, providing valuable information for prognosis and treatment decisions.

The IMMUNOHISTOCHEMISTRY CD45 LCA Test is also useful in distinguishing lymphomas from other types of cancers and classifying different subtypes of lymphomas.

Overall, this test is an important tool in pathology for the identification and characterization of leukocytes in tissue samples. It aids in the diagnosis and classification of various diseases, particularly cancers involving the immune system.

Test Name IMMUNOHISTOCHEMISTRY CD45 LCA Test
Components
Price 410.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department:
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The immunohistochemistry CD45 (LCA) test is a diagnostic test used in pathology to identify and characterize certain types of cells in tissue samples. CD45, also known as leukocyte common antigen (LCA), is a protein that is present on the surface of all white blood cells (leukocytes).

The CD45 test involves staining tissue sections with antibodies specific to CD45. These antibodies bind to CD45 protein on the surface of leukocytes, allowing the identification and localization of these cells within the tissue sample. The test can be performed on formalin-fixed, paraffin-embedded tissue sections or frozen tissue sections.

The CD45 test is commonly used to differentiate between malignant and non-malignant cells in various types of cancers. It can help determine the presence and distribution of leukocytes within the tumor microenvironment, which can provide valuable information for prognosis and treatment decisions. CD45 expression can also be used to distinguish lymphomas from other types of cancers and to classify different subtypes of lymphomas.

Overall, the immunohistochemistry CD45 (LCA) test is an important tool in pathology for the identification and characterization of leukocytes in tissue samples, aiding in the diagnosis and classification of various diseases, particularly cancers involving the immune system.